On October 1, the State of Ohio Board of Pharmacy (SOBP) voted to classify kratom as a Schedule I controlled substance alongside heroin, LSD, and other dangerous illegal drugs. The board concluded kratom has a high potential for abuse, has no accepted medical use, isn’t safe to use in medical treatment, and poses a public health risk. Public comment on this decision is being sought and will be accepted through close of business on Thursday, October 18.
Mitragynine and 7-hydroxymitragynine are the main active constituents of the plant kratom. Kratom is a plant-based supplement that consumers say alleviates chronic pain and opioid addiction.